Registration - In-house Corporation

LEO PHARMA INC. / Jill Archibald, General Manager

Registration Information

In-house Corporation name: LEO PHARMA INC.
Responsible Officer Name: Jill Archibald, General Manager
Responsible Officer Change History
Initial registration start date: 1999-02-12
Registration status: Active
Registration Number: 952071-12014

Associated Communications

Total Number of Communication Reports: 9

Monthly communication reports in the last 6 months: 0

Version 3 of 8 (2018-10-16 to 2019-03-01)

Registration versions:

Version 3 of 8 (2018-10-16 to 2019-03-01)

Lobbying Information

Subject Matters

Health

Subject Matter Details

Regulation

Lobbying as it relates to pharmaceutical pricing reforms under the Patented Medicines Pricing Review Board (PMPRB). The PMPRB has proposed a new regulatory framework (under Health Canada). Our lobbying efforts will be focusing on discussing alternatives to the proposed PMPRB framework.

Communication Techniques

Written communication
Oral communication

Government Institutions

Canadian International Trade Tribunal (CITT)
Finance Canada (FIN)
Health Canada (HC)
House of Commons
National Research Council (NRC)
Patented Medicine Prices Review Board (PMPRB)
Treasury Board Of Canada Secretariat (TBS)

Government institutions added through a monthly communication report

Global Affairs Canada (GAC)
Indigenous Services Canada (ISC)
Innovation, Science and Economic Development Canada (ISED)

In-house Corporation Details

Description of activities

LEO Pharma Canada is a division of LEO Pharma A/S, a global, brand name, research-based pharmaceutical company, specializing in skin health and thrombosis (blood clots). For more than a century across the globe, and for over 30 years in Canada. LEO is a unique pharmaceutical company in that we are independently owned by the LEO Foundation. 100% of our profits are reinvested in LEO Pharma to discover new solutions, reinforcing our relentless commitment to help as many patients as we can.

Responsible officer name and position during the period of this registration

Kristian Fick, COUNTRY LEAD

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
123 Commerce Valley Drive East, Suite 400
Thornhill, ON L3T 7W8
Canada

Telephone number: 905-747-2352

Parent Company Information

LEO PHARMA INC. is not a subsidiary of any other parent companies.

Subsidiary Beneficiary Information

LEO PHARMA INC. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

No lobbyists added

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Kristian Fick, COUNTRY LEAD | No public offices held
Monica Soos, EXTERNAL RELATIONS MANAGER | No public offices held

LEO PHARMA INC.

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
LEO PHARMA INC.	2018-08-24	current

The following names have been used before July 2, 2008

LEO PHARMA INC.

LEO PHARMA INC.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Jill Archibald	2022-04-25	Current
Goncalo Goya	2021-08-16	2022-04-25
Kristian Fick	2018-08-24	2020-06-16
GREGORY HINES	1999-02-12	2000-02-29

Jill Archibald, General Manager (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-9 of 9

LEO PHARMA INC.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dr. Stephen Ellis, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2023-08-03
Posted date: 2023-10-03
Communication number: 12014-577542 View associated registration
LEO PHARMA INC.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mitch Davies, Sr Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)
- Jocelyn Milburn, Officer | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry
Communication date: 2019-12-05
Posted date: 2019-12-16
Communication number: 12014-461840 View associated registration
LEO PHARMA INC.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2019-11-21
Posted date: 2019-12-16
Communication number: 12014-461847 View associated registration
LEO PHARMA INC.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David Lee, Chief Regulatory Officer | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2019-06-12
Posted date: 2019-07-02
Communication number: 12014-456610 View associated registration
LEO PHARMA INC.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Supriya Sharma, Chief Medical Advisor, HC / Senior Medical Advisor for HPFB | Health Canada (HC)
- Marcel Saulnier, Associate ADM | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2019-05-08
Posted date: 2019-05-24
Communication number: 12014-453534 View associated registration
LEO PHARMA INC.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Arthur Lam, Sr Advisor | MINISTER OF SMALL BUSINESS AND EXPORT PROMOTION | Innovation, Science and Economic Development Canada (ISED)
- Emily Yorke, Policy Advisor | Finance Canada (FIN)
- Janet MacPhee, Senior Investment Officer | Global Affairs Canada (GAC)
- Zoe Hawa, Deputy Director | Global Affairs Canada (GAC)
Subject Matter of the communication: Health
Communication date: 2019-02-26
Posted date: 2019-03-01
Communication number: 12014-446332 View associated registration
LEO PHARMA INC.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kate Moussouni, Senior Policy Advisor | Health Canada (HC)
- Rodrigo Arancibia, Director, Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
- Benoit Leduc, Manager | Innovation, Science and Economic Development Canada (ISED)
- Kate Proctor, Policy Advisor | Treasury Board Of Canada Secretariat (TBS)
- Kevin Deagle, Policy Advisor | Indigenous Services Canada (ISC)
- Joseph Wabegijig, Policy Advisor | Indigenous Services Canada (ISC)
Subject Matter of the communication: Health
Communication date: 2018-11-16
Posted date: 2018-11-30
Communication number: 12014-440528 View associated registration
LEO PHARMA INC.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mary Ng, Member of Parliament | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2018-10-09
Posted date: 2018-10-16
Communication number: 12014-436135 View associated registration
LEO PHARMA INC.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Oliver, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2018-08-27
Posted date: 2018-08-30
Communication number: 12014-432933 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

LEO PHARMA INC. / Jill Archibald, General Manager

Registration Information

Associated Communications

Version 3 of 8 (2018-10-16 to 2019-03-01)

Version 3 of 8 (2018-10-16 to 2019-03-01)

Subject Matters

Subject Matter Details

Regulation

Communication Techniques

Government Institutions

Government institutions added through a monthly communication report

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties